Paul J. Clancy - Insider Trading & Ownership

Entity
Individual
Location
C/O Biogen Idec Inc., 14 Cambridge Center, Cambridge, MA
Summary
The estimated net worth of Paul J. Clancy is at least $2.54M dollars as of January 3, 2025. Paul J. Clancy is the Director of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $1.36M. Paul J. Clancy is the Director of EXACT SCIENCES CORP and owns shares of EXACT SCIENCES CORP (EXAS) stock worth about $1.06M. Paul J. Clancy is the Director of AGIOS PHARMACEUTICALS, INC. and owns shares of AGIOS PHARMACEUTICALS, INC. (AGIO) stock worth about $123K.
All Insider Reports
All Insider Reports

Ownership of Paul J. Clancy

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
INCY INCYTE CORP Director $1.36M Dec 31, 2024
EXAS EXACT SCIENCES CORP Director $1.06M Jun 13, 2024
AGIO AGIOS PHARMACEUTICALS, INC. Director $123K Jun 21, 2022
XLO Xilio Therapeutics, Inc. Director Jun 14, 2024

Insider Transactions Reported by Paul J. Clancy:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.